The Iran Project - A senior Iranian health official has praised Iran's progress in the field of medical science and pharmaceutical industry, highlighting the export of Iranian-developed medicines to 40 countries worldwide.

Heidar Mohammadi, the head of Iran's Food and Drug Administration, made the remark during the Iran Pharma Expo in Tehran.

Mohammadi noted that the threefold increase in pharmaceutical exports reflects Iran's positive interaction with neighboring countries.

Speaking on the sidelines of the 2023 edition of Iran Pharma Expo in Tehran, Mohammadi said the presence of representatives from foreign countries is one of the greatest achievements of the exhibition.

The three-day exhibition,�which is hailed as one of the biggest pharmaceutical events in the West Asian region, wrapped up today.

The exhibition, which is considered one of the largest pharmaceutical events in the region, featured representatives from foreign countries and showcased Iran's pharmaceutical capabilities.

Mohammadi emphasized the importance of expanding access to quality medicines in the region through regional cooperation initiatives such as the Group of Five (G5) mechanism.

The G5 initiative, launched by Iran in 2005, aims to enhance subregional cooperation between Iran, Afghanistan, Iraq, Pakistan, and Tajikistan.

The Iran Pharma Expo, organized by the Iranian Pharmaceutical Industries Syndicate and the Ministry of Health, provides a platform for industry professionals to showcase Iran's pharmaceutical potentials and capabilities.